DiviDrip · CNTB

CNTB — Connect Biopharma Holdings Limited

CNTB is Connect Biopharma Holdings Limited (Healthcare) — a non-dividend-paying stock. Trading at $2.76. Market cap: $149M. Capital Quality Rank: 65/100 — Above average.

Stock snapshot

Price$2.76
Market cap$149M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)65 / 100 · Above average
ROIC (TTM)-440.7%
Shareholder buyback yield-0.80%
Altman Z-score zoneGrey

About CNTB

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Listed2025Employees64HQSan Diego, CASectorHealthcareWebsiteconnectbiopharm.com

Related non-dividend companies

Other non-dividend stocks investors research alongside CNTB. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is CNTB's current stock price?

CNTB (Connect Biopharma Holdings Limited) is currently trading at $2.76.

Does CNTB pay a dividend?

CNTB (Connect Biopharma Holdings Limited) does not currently pay a regular dividend.

What is CNTB's Capital Quality Rank?

CNTB has a Capital Quality Rank of 65/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track CNTB in DiviDrip

Add CNTB to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow